Search Results 341-350 of 24218 for In situ

1. A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer - Mayo Clinic

   placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in ... EXCEPTIONS: Non-melanoma skin cancer or carcinoma-in-situ (e.g. of cervix, prostate).

2. Study Of SIM0500 Alone In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   Current or previous other malignancy within 3 years of study entry, except basal or squamous cell skin cancer, superficial bladder cancer, or carcinoma in situ ...

3. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Curatively treated basal cell carcinoma or squamous cell carcinoma of the skin or carcinoma in situ of the cervix or carcinoma in situ of the prostate at any ...

4. Khashayarsha Khazaie, Ph.D. - Mayo Clinic Faculty Profiles

   Multiplex in situ immunostaining is used for side-by-side comparison of the microenvironments of the ectopic endometrium and endometrial cancer metastasis in ...

5. Breast cancer types: What your type means - Mayo Clinic

   Ductal carcinoma in situ, also called DCIS, is a type of breast cancer that's not invasive. It happens when cancer cells form in a breast duct. The cancer cells ...

6. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...

7. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   ... in Combination With Gilteritinib in Subjects With Relapsed ... Adequately treated in situ carcinoma of the cervix uteri or carcinoma in situ of breast; ...

8. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   Exceptions are colonic polyps, non-melanoma skin cancer or carcinoma in-situ of the cervix. Any of the following because this study involves an agent that ...

9. Genetics of Chemotherapy-Related Amenorrhea in Breast Cancer Survivors - Mayo Clinic

   Has never been diagnosed with a cancer other than breast cancer (besides non-melanoma skin cancer or carcinoma in situ of the cervix); Willing to allow us to ...

10. Rollover Study Of Cenicriviroc For The Treatment Of Liver Fibrosis In Participants With Nonalcoholic Steatohepatitis - Mayo Clinic

    ... in situ [DCIS] 12 gene recurrence score < 39 for noninvasive breast cancer). Participating Mayo Clinic locations. Study statuses change often. Please contact ...